| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |